213 related articles for article (PubMed ID: 27301956)
1. HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.
Wang C; Jing H; Sha D; Wang W; Chen J; Cui Y; Han J
BMC Infect Dis; 2016 Jun; 16():295. PubMed ID: 27301956
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Jeong S; Tong Y; Sha M; Gu J; Xia Q
Oncotarget; 2017 Mar; 8(10):17292-17300. PubMed ID: 28030846
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
Vij K; Wang HL
Int J Surg Pathol; 2008 Apr; 16(2):194-8. PubMed ID: 18417680
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.
Lei Z; Xia Y; Si A; Wang K; Li J; Yan Z; Yang T; Wu D; Wan X; Zhou W; Liu J; Wang H; Cong W; Wu M; Pawlik TM; Lau WY; Shen F
J Hepatol; 2018 Apr; 68(4):655-662. PubMed ID: 29155069
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.
Song Z; Lin S; Wu X; Ren X; Wu Y; Wen H; Qian B; Lin H; Huang Y; Zhao C; Wang N; Huang Y; Peng B; Li X; Peng H; Shen S
Hepatol Int; 2023 Oct; 17(5):1300-1317. PubMed ID: 37368186
[TBL] [Abstract][Full Text] [Related]
6. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.
Ahn JM; Paik YH; Lee JH; Cho JY; Sohn W; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Clin Mol Hepatol; 2015 Dec; 21(4):393-7. PubMed ID: 26770929
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
[TBL] [Abstract][Full Text] [Related]
9. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
[TBL] [Abstract][Full Text] [Related]
10. Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population.
Li Y; Wang H; Li D; Hu J; Wang H; Zhou D; Li Q; Jiang X; Zhou H; Hu H
J Clin Gastroenterol; 2014; 48(10):878-82. PubMed ID: 24356457
[TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
12. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus infection and intrahepatic cholangiocarcinoma.
Zhou HB; Hu JY; Hu HP
World J Gastroenterol; 2014 May; 20(19):5721-9. PubMed ID: 24914333
[TBL] [Abstract][Full Text] [Related]
14. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L
J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811
[TBL] [Abstract][Full Text] [Related]
15. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature.
Qu MM; Zhu YH; Li YX; Li ZF; Li JK; Xu YS; Shrestha M; Lei JQ
Medicine (Baltimore); 2021 Nov; 100(46):e27349. PubMed ID: 34797273
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection-associated cholangiocarcinoma: a report of one case and the review of literature.
Zhang X; Wang N; Wei W; Li Y
Virol J; 2022 Aug; 19(1):133. PubMed ID: 35945590
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.
Zhou HB; Wang H; Li YQ; Li SX; Wang H; Zhou DX; Tu QQ; Wang Q; Zou SS; Wu MC; Hu HP
World J Gastroenterol; 2011 Mar; 17(10):1292-303. PubMed ID: 21455328
[TBL] [Abstract][Full Text] [Related]
18. Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Yoon YM; Kang DY; Kim DY; Seo JW; Lim HJ; Lee HJ; Park SG
J Med Case Rep; 2016 Jun; 10(1):140. PubMed ID: 27246404
[TBL] [Abstract][Full Text] [Related]
19. Cholangiolocellular carcinoma with rapid progression initially showing abnormally elevated serum alfa-fetoprotein.
Yoh T; Kato T; Hirohata Y; Nakamura Y; Nakayama H; Okamura R
Clin J Gastroenterol; 2016 Aug; 9(4):257-60. PubMed ID: 27363839
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic cholangiocarcinoma arising in chronic viral hepatitis-associated cirrhosis: two transplant cases.
Nart D; Ertan Y; Pala EE; Zeytunlu M; Kilic M; Yilmaz F
Transplant Proc; 2008 Dec; 40(10):3813-5. PubMed ID: 19100500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
